Chris Caldwell's most recent trade in Concentrix Corporation was a trade of 1,000 Common Stock done at an average price of $46 . Disclosure was reported to the exchange on April 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 46.00 per share. | 21 Apr 2025 | 1,000 | 303,362 | - | 46 | 46,000 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.28 per share. | 01 Feb 2025 | 4,878 | 302,362 | - | 52.3 | 255,022 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 5,774 | 308,646 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.96 per share. | 29 Jan 2025 | 1,406 | 307,240 | - | 54.0 | 75,868 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 70,574 | 305,479 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.51 per share. | 24 Jan 2025 | 1,490 | 302,872 | - | 53.5 | 79,730 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.54 per share. | 24 Jan 2025 | 1,117 | 304,362 | - | 52.5 | 58,687 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.95 per share. | 01 Dec 2024 | 6,574 | 234,905 | - | 44.9 | 295,501 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.62 per share. | 07 Oct 2024 | 362 | 241,479 | - | 51.6 | 18,686 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 12,928 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.39 per share. | 04 Oct 2024 | 12,928 | 251,664 | - | 31.4 | 405,810 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 52.70 per share. | 04 Oct 2024 | 9,823 | 241,841 | - | 52.7 | 517,708 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 02 Oct 2024 | 392 | 238,736 | - | 51.7 | 20,266 | Common Stock |
Brinker International, Inc. | Chris Caldwell | SVP, Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 3,133 | 3,133 (0%) | 0% | 0 | Common Stock | |
Brinker International, Inc. | Chris Caldwell | SVP, Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 2,564 | 2,564 (0%) | 0% | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 54.59 per share. | 19 Apr 2024 | 900 | 239,128 | - | 54.6 | 49,131 | Common Stock |
Concentrix Corporation | Caldwell Christopher A. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 40,322 | 238,228 | - | 0 | Common Stock | |
Concentrix Corporation | Caldwell A. Christopher | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.20 per share. | 26 Jan 2024 | 1,490 | 197,906 | - | 92.2 | 137,378 | Common Stock |
Concentrix Corporation | Caldwell Christopher A. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.08 per share. | 26 Jan 2024 | 1,066 | 199,396 | - | 91.1 | 97,091 | Common Stock |
Concentrix Corporation | A. Christopher Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.53 per share. | 01 Dec 2023 | 6,574 | 200,462 | - | 94.5 | 621,440 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 24,465 | 208,360 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.82 per share. | 26 Jan 2023 | 1,042 | 183,895 | - | 141.8 | 147,776 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.73 per share. | 01 Dec 2022 | 6,574 | 184,937 | - | 121.7 | 800,253 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.11 per share. | 11 Oct 2022 | 570 | 191,511 | - | 120.1 | 68,463 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.55 per share. | 07 Oct 2022 | 362 | 192,081 | - | 120.5 | 43,639 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.51 per share. | 02 Oct 2022 | 917 | 192,650 | - | 117.5 | 107,757 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.51 per share. | 02 Oct 2022 | 207 | 192,443 | - | 117.5 | 24,325 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 14,007 | 198,325 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.79 per share. | 07 Feb 2022 | 4,758 | 193,567 | - | 198.8 | 945,843 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.88 per share. | 11 Oct 2021 | 570 | 165,739 | - | 179.9 | 102,532 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 181.50 per share. | 07 Oct 2021 | 362 | 166,309 | - | 181.5 | 65,703 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.94 per share. | 02 Oct 2021 | 392 | 167,115 | - | 174.9 | 68,576 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.94 per share. | 02 Oct 2021 | 237 | 166,671 | - | 174.9 | 41,461 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.94 per share. | 02 Oct 2021 | 207 | 166,908 | - | 174.9 | 36,213 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 65,032 | 199,750 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 151.10 per share. | 01 Jun 2021 | 32,243 | 167,507 | - | 151.1 | 4,871,917 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 5,647 | 136,715 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.35 per share. | 28 Jan 2021 | 1,997 | 134,718 | - | 116.4 | 232,351 | Common Stock |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2021 | 83,528 | 126,474 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2021 | 26,212 | 26,212 | - | - | Employee Stock Option (Right to Buy) | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2021 | 4,594 | 131,068 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 45,808 | 45,808 | - | - | Employee Stock Option (Right to Buy) | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 42,946 | 42,946 | - | 0 | Common Stock | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 30,057 | 30,057 | - | - | Employee Stock Option (Right to Buy) | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 12,928 | 12,928 | - | - | Employee Stock Option (Right to Buy) | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 12,630 | 12,630 | - | - | Employee Stock Option (Right to Buy) | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 11,172 | 11,172 | - | - | Employee Stock Option (Right to Buy) | |
Concentrix Corporation | Christopher A. Caldwell | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 9,363 | 9,363 | - | - | Employee Stock Option (Right to Buy) | |
TD Synnex Corp | Christopher A. Caldwell | President, Concentrix | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2020 | 9,389 | 47,846 (0%) | 0% | 0 | Common Stock | |
TD Synnex Corp | Christopher A. Caldwell | President, Concentrix | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.21 per share. | 20 Oct 2020 | 4,900 | 42,946 (0%) | 0% | 147.2 | 721,329 | Common Stock |
TD Synnex Corp | Christopher A. Caldwell | President, Concentrix | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.47 per share. | 12 Oct 2020 | 756 | 38,457 (0%) | 0% | 150.5 | 113,755 | Common Stock |
TD Synnex Corp | Christopher A. Caldwell | President, Concentrix | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.60 per share. | 03 Oct 2020 | 315 | 39,447 (0%) | 0% | 150.6 | 47,439 | Common Stock |
TD Synnex Corp | Christopher A. Caldwell | President, Concentrix | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.60 per share. | 03 Oct 2020 | 264 | 39,762 (0%) | 0% | 150.6 | 39,758 | Common Stock |
TD Synnex Corp | Christopher A. Caldwell | President, Concentrix | Payment of exercise price or tax liability using portion of securities received from the company at price $ 151.92 per share. | 03 Oct 2020 | 234 | 39,213 (0%) | 0% | 151.9 | 35,549 | Common Stock |
TD Synnex Corp | Christopher A. Caldwell | President, Concentrix | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.64 per share. | 02 Oct 2020 | 375 | 40,026 (0%) | 0% | 147.6 | 55,365 | Common Stock |